Oralia Barboza‐Quintana

Oralia Barboza‐Quintana

Auto-generated profile, based on publicly available information

Oralia Barboza‐Quintana

Department of Anatomical Pathology and Cytopathology, University Hospital “Dr. José Eleuterio González”, Monterrey, Nuevo Leon, Mexico

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
ACAdrian Cuellar‐Barboza
Adrian Cuellar‐Barboza
JGJesus Alberto Cardenas-de la Garza
Jesus Alberto Cardenas-de la Garza
LCLuis Gerardo Cruz‐Gómez
Luis Gerardo Cruz‐Gómez
OBOralia Barboza‐Quintana
Oralia Barboza‐Quintana
JFJuan Pablo Flores‐Gutiérrez
Juan Pablo Flores‐Gutiérrez
MHMaira E. Herz‐Ruelas
Maira E. Herz‐Ruelas

8 August 2019 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
PDF file
MBMaría Carmen Barboza-Cerda
María Carmen Barboza-Cerda
OBOralia Barboza‐Quintana
Oralia Barboza‐Quintana
GMGerardo Martínez‐Aldape
Gerardo Martínez‐Aldape
RGRaquel Garza‐Guajardo
Raquel Garza‐Guajardo
MDMiguel Ángel Déctor
Miguel Ángel Déctor
Background: Male EBP disorder with neurologic defects (MEND) syndrome is an X‐linked disease caused by hypomorphic mutations in the EBP (emopamil‐binding protein) gene. Modifier genes may explain the clinical variability among individuals who share a primary mutation.Methods: We studied four males (Patient 1 to Patient 4) exhibiting a descending degree of phenotypic severity from a family with MEND syndrome. To identify candidate modifier genes that explain the phenotypic variability, variants of homeostasis cholesterol genes identified by whole‐exome sequencing (WES) were ranked according to the predicted magnitude of their effect through an in‐house scoring system.Results: Twenty‐seven from 105 missense variants found in 45 genes of the four exomes were considered significant (−5 to −9 scores). We found a direct genotype–phenotype association based on the differential accumulation of potentially functional gene variants among males. Patient 1 exhibited 17 variants, both Patients 2 and 3 exhibited nine variants, and Patient 4 exhibited only five variants.Conclusion: We conclude that APOA5 (rs3135506), ABCA1 (rs9282541), and APOB (rs679899 and rs12714225) are the most relevant candidate modifier genes in this family. Relative accumulation of the deficiencies associated with variants of these genes along with other lesser deficiencies in other genes appears to explain the variable expressivity in MEND syndrome.

8 October 2018 in The Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
JGJesus Alberto Cardenas-de la Garza
Jesus Alberto Cardenas-de la Garza
JAJesus Ancer‐Arellano
Jesus Ancer‐Arellano
ACAdrian Cuellar‐Barboza
Adrian Cuellar‐Barboza
BSBarbara Saenz‐Ibarra
Barbara Saenz‐Ibarra
Sonia Sofía Ocampo-GarzaSonia Sofía Ocampo-Garza
Sonia Sofía Ocampo-Garza
OWOliverio Welsh
Oliverio Welsh

1 January 2025 in Case Reports in Pathology
Verified
Journal Article
Open access
JOJessica A. Ortega-Balderas
Jessica A. Ortega-Balderas
HRHayde S. Ramos-Marrero
Hayde S. Ramos-Marrero
RGRaquel Garza-Guajardo
Raquel Garza-Guajardo
OBOralia Barboza-Quintana
Oralia Barboza-Quintana
BSBarbara Saenz-Ibarra
Barbara Saenz-Ibarra
Primary intracranial pure yolk sac tumors (YSTs) are rare, and their typical histological findings have been documented in the literature. We report a case of a 20‐year‐old young man with an intra‐axial primary YST exhibiting a unique sarcomatoid morphology. This case demonstrates that primary intracranial YSTs present uncommon patterns underscoring the importance of including YSTs in the differential diagnosis of midline masses. To the best of our knowledge, this is the first reported pure primary intracranial YST showing sarcomatoid histology.